Fong Ming Koh is a trained developmental biologist with a PhD from UCSF who switched to venture capital investing, bringing unusually deep technical expertise in stem cells, epigenetics, and cancer biology to his role as an Asia-focused biopharma investor at LYFE Capital. He actively builds Singapore's life science startup community as a long-time volunteer leader at Biotech Connection Singapore and serves on organizing committees for major industry conferences, positioning him as both a capital provider and hands-on ecosystem connector between Western and Asian biotech leaders.